Ottawa doctors' high-risk MS treatment yields 'impressive' results, Lancet finds

New Canadian research led by two Ottawa doctors and published in The Lancet medical journal on Thursday suggests a high-risk therapy may stop multiple sclerosis from progressing, and even reverse the disease.